Target intelligence / Profile preview

Laminin subunit alpha-1 (LAMA1)

Target
LAMA1
Molecular classification
Extracellular matrix glycoprotein, Basement membrane constituent, Structural protein
01

Overview

Laminin subunit alpha-1 is a large extracellular matrix glycoprotein that, along with beta and gamma chains, forms heterotrimeric laminin molecules essential for the structure and function of basement membranes in nearly all animal tissues. The laminin alpha-1 chain is crucial for organizing cell layers, mediating cell adhesion, migration, tissue development, and maintenance of extracellular matrix architecture. Mutations in *LAMA1* are linked to Poretti–Boltshauser syndrome, a rare developmental disorder. Laminins interact with high-affinity cell-surface receptors mediating tissue-specific functions and cellular behaviors, but are not classical drug targets[1][2][3][4][5][6][7].

Other names
Laminin alpha chainLAMA1alpha-1 laminin
02

Mechanism of action

Not applicable—no drugs with direct mechanisms of action targeting laminin subunit alpha chains.

03

Biological functions

Cell adhesionCell migrationCellular organization into tissuesStructural scaffolding for basement membranes
04

Disease associations

Cancer (altered matrix composition)Poretti–Boltshauser syndrome (LAMA1 mutations)Developmental disordersPotential role in neurodegenerative and genetic diseases
05

Safety considerations

Notable safety issues do **not** exist for therapeutic targeting, but altered laminin expression can impact tissue integrity and disease progression in pathologies such as cancer and congenital basement membrane disorders
06

Interacting drugs

None known as direct binders/therapeutics. No FDA-approved drugs directly target laminin subunit alpha chains; however, laminin-rich matrices are used in research and regenerative medicine.
07

Biomarkers

LAMA1 mutation testing in genetic screening for Poretti–Boltshauser syndrome.Laminin levels can be used as markers of basement membrane integrity and tissue remodeling in certain cancers and inflammatory conditions

Beyond the preview

Go deeper on Laminin subunit alpha-1 (LAMA1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Laminin subunit alpha-1 (LAMA1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call